AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Insight Molecular Diagnostics Inc. Director's Dealing 2025

Jul 3, 2025

34238_dirs_2025-07-03_548f1d4e-fc30-4b2a-8af1-9be017d580ed.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Insight Molecular Diagnostics Inc. (IMDX)
CIK: 0001642380
Period of Report: 2025-07-01

Reporting Person: SILVERMAN LOU (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-07-01	Common Stock, no par value	A	35000	—	Acquired	36564	Direct

Footnotes

F1: The Restricted Stock Units shall vest one year from the date of grant, subject to the Reporting Person's continued service from the date of grant until the vesting date or, if earlier, until the next annual meeting of shareholders.